NCT06388824

The Effect of Esketamine on Sleep Disturbance

The Effect of a Single Low Dose of Esketamine During Surgical Abortion in Patients With Sleep Disturbance

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 204 (actual)
• Sponsor: Tianjin Medical University General Hospital · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To explore the efficacy of a single low dose of esketamine during surgical abortion in patients with sleep disturbance

Detailed description

Sleep disturbance occur in the form of sleep deprivation, circadian rhythm disturbance, and structural abnormalities. Women who requires surgical abortion due to fetal anomaly or unwanted pregnancy often experience sleep disturbance. Severe sleep disturbance is a strong indicator for postoperative sleep disorders, which can lead to postoperative delirium and cognitive dysfunction, aggravate postoperative pain, and delay postoperative recovery. Esketamine is an N-methyl-D-aspartate(NMDA) receptor antagonist with analgesic and sedative effects, and is widely used in clinical treatment of refractory depression. For patients undergoing surgical abortion, in addition to sedation and analgesia, whether the intraoperative use of esketamine has positive effects on sleep disturbance is worth exploring.

Conditions

• Sleep Disturbance

Interventions

Type	Name	Description
DRUG	normal saline	Patients undergoing surgical abortion received a single injection of 5ml 0.9% normal saline after the beginning of surgery
DRUG	Esketamine	Patients undergoing surgical abortion received a single injection of 0.2mg/kg esketamine after the beginning of surgery

Timeline

• Start date: 2024-05-03
• Primary completion: 2024-11-07
• Completion: 2024-11-13
• First posted: 2024-04-29
• Last updated: 2025-02-12

Locations

1 site across 1 country: China